Susan Hockfield

Susan Hockfield     (scientist)
Born	1951-03-24 Chicago, Illinois
Nationality	US
Alma mater	University of Rochester, Georgetown University School of Medicine
Spouse	Thomas N. Byrne
Member of	Belfer Center for Science and International Affairs, Council on Foreign Relations/Members, WEF/Board of Trustees
President of Massachusetts Institute of Technology 2004-2012.  President of the Massachusetts Institute of Technology In office 2004 - 2012

Susan Hockfield is an American neuroscientist who was appointed a director of Pfizer in March 2020.. Hockfield was the first biologist and the first woman to be MIT president. Hockfield, Professor of Neuroscience in MIT's Department of Brain and Cognitive Sciences and a member of the Koch Institute for Integrative Cancer Research, is a director of General Electric and of Qualcomm. She is a trustee of the Carnegie Corporation of New York, and a member of the MIT Corporation. Before returning to MIT following her presidency, Hockfield held the Marie Curie Visiting Professorship at Harvard University's John F. Kennedy School of Government.

Education and early career

She attended Horace Greeley High School in Chappaqua, New York and graduated in 1969. She received her bachelor's degree in biology from the University of Rochester in 1973 and her Ph.D in Anatomy and Neuroscience from the Georgetown University School of Medicine in 1979. Her doctoral dissertation centered on the subject of pathways in the nervous system through which pain is perceived and processed. Her advisor during her doctoral work was Stephen Gobel.

Following a postdoctoral fellowship at the University of California, San Francisco, Hockfield joined the staff of the Cold Spring Harbor Laboratory in 1980: she was hired by James Watson, who, with Francis Crick had discovered the structure of DNA.

In 1985, Hockfield joined the faculty of Yale University. She received tenure in 1991 and became a full professor of neurobiology in 1994; soon thereafter she began to take on positions of administrative leadership. From 1998 to 2002, she served as Dean of the Graduate School of Arts and Sciences, with oversight of 70 graduate programs. Over the course of her deanship, the number of applicants to the graduate school doubled while graduate student support expanded in many dimensions, including healthcare, career counseling, fellowships, and opportunities to interact with faculty.

In December 2002, she was named Yale's Provost, the university's second-highest officer, with oversight of the university's 12 schools. As Provost, she led major initiatives in science, medicine, and engineering, including a $500 million investment in scientific facilities.

During her time as dean and provost, Hockfield was at the center of the struggle against the Graduate Employees and Students Organization and its unionization efforts. While Yale opposed the Graduate Employee union, Hockfield gave some concessions

In August 2004, the Massachusetts Institute of Technology named Hockfield its next president.

Scientific research

Hockfield pioneered the use of monoclonal antibody technology in brain research and discovered a gene that plays a critical role in the spread of cancer in the brain. Hockfield's early work involved the application of monoclonal antibody technology to questions within neurobiology. At the time, she was concerned with the development of cells in the brain and was a pioneer in the use of monoclonal antibodies in research on the brain. She discovered proteins that cause structural changes in early childhood brain development.

A link between her research and human health was made when it was suggested that one of these proteins played a role in the progression of brain tumors. Hockfield's work on one type of brain tumor called glioma identified molecules that allow glioma cells to move through normal brain tissue, the feature that makes glioma particularly deadly.

MIT presidency

Hockfield's presidency saw the most successful period of fundraising in MIT history, during which MIT raised nearly $3 billion. However, the global financial crisis put great pressure on the Institute's endowment, which was valued at $5.9 billion upon Hockfield's arrival. It peaked at $9.9 billion in June 2008, then fell to $7.9 billion. By June 2011, it was valued at $9.7 billion.

In her inaugural address, Hockfield called for MIT to cultivate the convergence of engineering and the life sciences to develop new approaches to address global challenges. Toward that end, she led, among other efforts, the establishment of the David H. Koch Institute for Integrative Cancer Research and the Ragon Institute of Massachusetts General Hospital, MIT, and Harvard University. She encouraged work that crossed disciplines, departments, and schools within MIT and that fostered collaborations among the Boston region's academic medical centers and educational institutions. She catalyzed the development of the Massachusetts Green High Performance Computing Center in Holyoke, Massachusetts, an unprecedented collaboration of 5 universities, 2 private companies, and the Commonwealth of Massachusetts to provide state-of-the art computation tools for research advances.

Hockfield also announced her intention to develop a multidisciplinary, Institute-wide center around energy. That effort spawned the MIT Energy Initiative, which raised more than $350 million during Hockfield's tenure and accelerated research on technologies and policies for a sustainable energy future. In 2009, U.S. President Barack Obama give a major address on U.S. energy policy at MIT, where Hockfield gave him the first tour of an MIT laboratory by a sitting U.S. president.

Hockfield encouraged concerted faculty research in an area she considered vital to the national interest: manufacturing. She launched “Production in the Innovation Economy,” a campus-wide project to provide a blueprint for 21st century manufacturing in America. During her presidency, she served as the inaugural co-chair of the White House–led Advanced Manufacturing Partnership (AMP), a task force of government, industry, and academic leaders. In an August 2011 New York Times op-ed, Hockfield wrote, “To make our economy grow, sell more goods to the world and replenish the work force, we need to restore manufacturing — not the assembly-line jobs of the past, but the high-tech advanced manufacturing of the future.”

In December 2011, MIT launched MITx, a not-for-profit online learning platform that offers online versions of MIT courses free of charge. In May 2012, Hockfield and Harvard president Drew Gilpin Faust announced edX, an MIT-Harvard partnership in online education. EdX, Hockfield said, “represents a unique opportunity to improve education on our own campuses through online learning, while simultaneously creating a bold new educational path for millions of learners worldwide.”

During Hockfield's presidency, the east side of MIT's campus was enhanced by an extension to the Media Lab complex and a new building for the MIT Sloan School of Management. Hockfield led a comprehensive strategic planning process for campus development and also worked to foster the innovation cluster around Kendall Square, which at the end of her presidency was home to more biotech and life sciences companies per square mile than anywhere in the world.

Personal life

Hockfield is married to Thomas N. Byrne, M.D (Clinical Professor of Neurology at the Harvard–MIT Division of Health Sciences and Technology). They were married on March 2, 1991 at Yale's Battell Chapel. They have a daughter, Elizabeth.

 

Events Participated in

Event	Start	End	Location(s)	Description
Bilderberg/2014	29 May 2014	1 June 2014	Denmark Copenhagen Marriott Hotel	The 62nd Bilderberg, with 136 guests, held in Copenhagen
WEF/Annual Meeting/2011	26 January 2011	30 January 2011	World Economic Forum Switzerland	2229 guests in Davos, with the theme: "Shared Norms for the New Reality".
WEF/Annual Meeting/2012	25 January 2012	29 January 2012	World Economic Forum Switzerland	2113 guests in Davos

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.